€300 million for Iberian BioTech and DeepTech as CriteriaCaixa rebrands its VC arm

July 13, 2026 at 02:50 PM UTC
EU-Startups
Original: EN
€300 million for Iberian BioTech and DeepTech as CriteriaCaixa rebrands its VC arm

CriteriaCaixa, the investment arm of 'la Caixa' Banking Foundation, has launched a significant initiative to bolster European deep tech and biotech sectors. The holding company is injecting €300 million through its specialized funds, Criteria Bio Ventures and Criteria Venture Tech, signaling a renewed commitment to fostering innovation within Spain, Portugal, and selectively across Europe and North America. This substantial investment aims to accelerate the growth of early-stage companies developing transformative therapies and technologies with the potential for broad societal impact and long-term value creation. This strategic allocation underscores a growing trend of European investment in cutting-edge scientific and technological fields. CriteriaCaixa's initiative arrives at a time when the region is witnessing increased funding in areas such as AI infrastructure, cybersecurity, and semiconductor development. Recent reports highlight substantial disclosed financing for companies in these domains, with Spanish startups alone securing a significant portion, indicating a robust pipeline of innovative ventures. The impact of this €300 million commitment is expected to be felt across the European tech ecosystem, particularly in Spain and Portugal. By supporting early-stage companies in critical sectors like BioTech, AI, and cybersecurity, CriteriaCaixa is not only driving economic growth but also contributing to Europe's digital sovereignty. This investment strengthens the continent's capacity to develop its own advanced technologies and reduces reliance on external players, a key objective in the current geopolitical landscape.

Curated and translated by Europe Digital for our multilingual European audience.

Why this matters for European digital sovereignty

CriteriaCaixa's €300 million investment in Iberian BioTech and DeepTech signifies a strengthened European commitment to nurturing transformative early-stage companies. This move bolsters the continent's strategic positioning in critical technological fields and contributes to Europe's digital sovereignty. The initiative aims to accelerate innovation within Spain, Portugal, and across the wider European ecosystem.

Source Information

Publication: EU-Startups
Published: July 13, 2026 at 02:50 PM UTC
All rights remain with the original publisher.